Insiders · Profile

Payne Fletcher

Chief Financial Officer at GYRE THERAPEUTICS. Filing since 17 Dec 2015. CIK 0001650476

Company
Date
Role
Action
Shares
Amount
Of holding
17 Dec 2015
Chief Financial Officer
Bought
10,000
$20.00K
66.5%
1 decision on file.